Peer-influenced content. Sources you trust. No registration required. This is HCN.
News Medical
In mice, psilocybin accelerated dendritic spine formation and maturation, with different remodeling patterns in stressed and healthy brains. Genetic experiments separated these structural effects from head-twitch behavior, a proxy rather than a direct measure of hallucinations.
Clinical Pharmacology November 10th 2026
Gastroenterology & Hepatology (G&H)
A review of pediatric inflammatory bowel disease describes how growth and inflammation alter biologic drug exposure. Evidence supporting proactive monitoring is strongest for anti-TNF therapies, while pediatric targets for newer agents remain less certain.
Clinical Pharmacology November 5th 2026
Verywell Health
A consumer overview describes metformin’s potential roles in weight management, ovarian syndrome symptoms, and cardiovascular outcomes, but the reported findings involve different populations and do not establish equivalent benefits across these uses.
Clinical Pharmacology November 3rd 2026
Specialty Pharmacy Continuum
Accreditors described new programs for artificial intelligence and immunoglobulin services, revised oncology dispensing materials, and more frequent DMEPOS surveys, with differing eligibility, payer recognition, and compliance implications across specialty pharmacy settings.
Pharmacy Practice News
Conference presenters highlighted gaps in menopause medication coverage and follow-up support, describing opportunities for pharmacist involvement while offering no comparative evidence that employer-sponsored programs improve symptoms, adherence, or workplace outcomes.
Clinical Infectious Diseases (CID)
Updated infectious diseases guidance addresses resistant gram-negative infections through pathogen-specific treatment pathways, incorporating newer antibiotics and pharmacologic considerations while acknowledging that several preferred approaches rest on limited clinical outcomes data.